Back

Novel biomarkers and indicators in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Univentricular heart, heart failure and pulmonary hypertension in congenital heart diseases Grown-up congenital heart disease and surgery ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Li Huang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

12 More presentations in this session

Presentation thumbnail
Ms P. Walker-Smith (Bristol, GB)
Abstract
Presentation thumbnail
Doctor A. Khan (Iowa City, US)
Abstract Slides
Presentation thumbnail
Doctor M. Possner (Bern, CH)
Abstract
Presentation thumbnail
Doctor V. Stoll (Cambridge, GB)
Abstract
Presentation thumbnail
Professor O. Tutarel (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Poster session 5 - Univentricular heart, heart failure and pulmonary hypertension in congenital heart diseases

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Session
Breaking the pressure: innovations in pulmonary hypertension management
18 May 2025
thumbnail
Congress Presentation
Reverse cardiac remodeling effects of sacubitril/valsartan in adults with congenital heart disease
20 May 2023
thumbnail
Congress Presentation
Reversibility and outcome of fenestrated surgical closure in adult patients with congenital left-to-right shunts and pulmonary hypertension: a result of cohard-ph registry
26 August 2023
thumbnail
Congress Presentation
Risk assessment tool implementation in congenital heart disease associated pulmonary arterial hypertension
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources